EP Patent

EP1338603A1 — Novel pyrazole derivatives and diabetes remedies containing the same

Assigned to Ajinomoto Co Inc · Expires 2003-08-27 · 23y expired

What this patent protects

The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine. <CHEM>

USPTO Abstract

The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine. <CHEM>

Drugs covered by this patent

Invokana (CANAGLIFLOZIN) · Johnson & Johnson

Patent Metadata

Patent number: EP1338603A1
Jurisdiction: EP
Classification: —
Expires: 2003-08-27
Drug substance claim: No
Drug product claim: No
Assignee: Ajinomoto Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.